Hello,
I think the correct answer is C, if yes, why or why not?
In countries in which new life-sustaining drugs cannot be patented, such drugs are sold at widely affordable prices; those same drugs, where patented, command premium prices because the patents shield patent-holding manufacturers from competitors. These facts show that future access to new life-sustaining drugs can be improved if the practice of granting patents on newly developed life-sustaining drugs were to be abolished everywhere.
Which of the following, if true, most seriously weakens the argument?
a) In countries in which life-sustaining drugs cannot be patented, their manufacture is nevertheless a profitable enterprise.
b) Countries that do not currently grant patents on life-sustaining drugs are, for the most part, countries with large populations.
c) In some countries specific processes for the manufacture of pharmaceutical drugs can be patented even in cases in which the drugs themselves cannot be patented.
d) Pharmaceutical companies can afford the research that goes into the development of new drugs only if patents allow them to earn high profits.
e) Countries that grant patents on life-sustaining drugs almost always ban their importation from countries that do not grant such patents.
Patents - weaken
This topic has expert replies
-
- Senior | Next Rank: 100 Posts
- Posts: 78
- Joined: Wed Jan 09, 2013 5:03 am
- Thanked: 9 times
- Followed by:4 members
- GMAT Score:700
Hello!
Ok I believe the correct answer is D
That is just my gut feeling. I'm sorry I can't give you an explanation why I think it is correct.
Ok I believe the correct answer is D
That is just my gut feeling. I'm sorry I can't give you an explanation why I think it is correct.
- charu_mahajan
- Master | Next Rank: 500 Posts
- Posts: 111
- Joined: Tue Jan 31, 2012 1:06 pm
- Thanked: 15 times
- Followed by:8 members
The argument concludes - future access to new life-sustaining drugs can be improved if the practice of granting patents were abolished
To Weaken this we need to find something that tells us that future access to new drugs will NOT be improved in case we abolish patents.
Consider option D - Pharmaceutical companies can afford the research that goes into the development of new drugs only if patents allow them to earn high profits. The money for research of new drugs will come from the patents' money. This makes our argument look like -
future access to new life-sustaining drugs CANNOT be improved if the practice of granting patents were abolished or
future access to new life-sustaining drugs can be improved if the practice of granting patents were NOT abolished
and hence is the CORRECT weakener.
To Weaken this we need to find something that tells us that future access to new drugs will NOT be improved in case we abolish patents.
Consider option D - Pharmaceutical companies can afford the research that goes into the development of new drugs only if patents allow them to earn high profits. The money for research of new drugs will come from the patents' money. This makes our argument look like -
future access to new life-sustaining drugs CANNOT be improved if the practice of granting patents were abolished or
future access to new life-sustaining drugs can be improved if the practice of granting patents were NOT abolished
and hence is the CORRECT weakener.